Cargando…
Alterations in Lipid Signaling Underlie Lipodystrophy Secondary to AGPAT2 Mutations
Congenital generalized lipodystrophy (CGL), secondary to AGPAT2 mutation is characterized by the absence of adipocytes and development of severe insulin resistance. In the current study, we investigated the adipogenic defect associated with AGPAT2 mutations. Adipogenesis was studied in muscle-derive...
Autores principales: | Subauste, Angela R., Das, Arun K., Li, Xiangquan, Elliot, Brandon, Evans, Charles, El Azzouny, Mahmoud, Treutelaar, Mary, Oral, Elif, Leff, Todd, Burant, Charles F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478532/ https://www.ncbi.nlm.nih.gov/pubmed/22872237 http://dx.doi.org/10.2337/db12-0004 |
Ejemplares similares
-
Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes 2012;61:2922–2931
por: Subauste, AR, et al.
Publicado: (2013) -
Depletion of Adipocyte Becn1 Leads to Lipodystrophy and Metabolic Dysregulation
por: Jin, Young, et al.
Publicado: (2021) -
Metreleptin and Metformin Use in an Infant With Congenital Generalized Lipodystrophy Secondary to AGPAT2 Mutation
por: Schweisberger, Cintya, et al.
Publicado: (2021) -
A Single Complex Agpat2 Allele in a Patient With Partial Lipodystrophy
por: Broekema, Marjoleine F., et al.
Publicado: (2018) -
Interactions Among Glucose Delivery, Transport, and Phosphorylation That Underlie Skeletal Muscle Insulin Resistance in Obesity and Type 2 Diabetes: Studies With Dynamic PET Imaging
por: Goodpaster, Bret H., et al.
Publicado: (2014)